Back to Invesco Ltd. Invesco Ltd.

SMMTSMMT

Showing 8 of 19 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in Summit Therapeutics Inc.

Yes. Invesco holds 416,847 shares of SMMT (Summit Therapeutics), worth $6.1M, as of its Q2 2026 13F filing. It reduced the position by 109,256 shares (-20.8%) from Q1 2026. Invesco has held SMMT since Q1 2023, across 14 quarterly 13F filings.

Current Value

$6.1M

Current Shares

416,847

Total Value Change

+$4.4M

Total Shares Change

+342,352

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
416,847
-20.8%
$6.1M0.0%$14.57
0
2026-Q1
Increased
526,103
+14.1%
$10M0.0%$18.96
32
2025-Q4
Increased
461,301
+8.3%
$8.1M0.0%$17.49
30
2025-Q3
Increased
426,075
+0.5%
$8.8M0.0%$20.66
28
2025-Q2
Increased
424,027
+8.8%
$9M0.0%$21.28
30
2025-Q1
Decreased
389,705
-2.3%
$7.5M0.0%$19.29
0
2024-Q4
Increased
399,050
+435.7%
$7.1M0.0%$17.85
44
2024-Q3
Increased
74,495
+3.9%
$1.6M0.0%$20.89
27

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used